DMK PHARMACEUTICALS CORPORATION: capex
| Value | {"amount": 847141, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-06-30 |
| Status | current |
| Entity | DMK PHARMACEUTICALS CORPORATION |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:54:25.189173+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/58ee87de-b86c-4ac8-8834-cff12f2acf01
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001387131-22-008584 · Open the official SEC filing →Retrieved: 2026-08-19T08:54:25.189173+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000887247/capex/2021-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/58ee87de-b86c-4ac8-8834-cff12f2acf01
History
- supersedes {"amount": 847830, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} (evidence 0001387131-21-011421)